OBJECTIVE Postprandial hyperglycemia is often inadequately assessed in diabetes management. Serum 1,5-anhydroglucitol (1,5-AG) drops as serum glucose rises above the renal threshold for glucose and has been proposed as a marker for postprandial hyperglycemia. The objective of this study is to demonstrate the relationship between 1,5-AG and postprandial hyperglycemia, as assessed by the continuo...

Glucagon has been shown effective for the treatment of insulinoma-associated hypoglycemia. However, its use limited to preoperative supportive care and emergency hypoglycemic crisis because need constant intravenous infusion administration. Here, we report a case insulinoma in dog managed with subcutaneous saline-diluted glucagon continuous glucose monitoring system (CGMS), which were glycemic ...

We aimed to estimate the impact of ingestion of a pure protein load on the glucose levels in T1DM patients treated with insulin pumps. We examined 10 T1DM patients (6 females, mean age-32.3 years, mean HbA1c-6.8%) treated with insulin pumps equipped with a continuous glucose monitoring system (CGMS). In Phase I, baseline insulin infusion was optimized to minimize the differences in fasting gluc...

BACKGROUND The identification of a marker for hypoglycemia could help patients achieve strict glucose control with a lower risk of hypoglycemia. 1,5-Anhydro-D-glucitol (1,5-AG) reflects postprandial hyperglycemia in patients with well-controlled diabetes, which contributes to glycemic variability. Because glycemic variability is related to hypoglycemia, we aimed to evaluate the value of 1,5-AG ...

In this paper a framework for fast face detection is presented. The features used in the system are low order Central Geometrical Moments (CGMs) of Face Components and their horizontal and vertical gradients. To speed up the detection process we have utilized a fast method to compute CGMs locally in the feature extraction phase, and in the classification phase we have used a fast multistage cla...

1. The aim of the present study was to compare the effects of glipizide controlled-release (CR) tablets monotherapy with that of glipizide CR tablets plus acarbose on glycaemic variability in newly diagnosed Type 2 diabetes (T2DM) patients using a continuous glucose-monitoring system (CGMS). 2. Forty newly diagnosed T2DM patients whose glycated haemoglobin A1c (HbA1c) levels ranged from 7.0% to...

BACKGROUND Addison's disease, or primary adrenal insufficiency, is often associated with reduced well-being and fatigue despite use of currently recommended adrenal hormone replacement. Hypoglycaemia is a known manifestation of glucocorticoid deficiency, but is generally considered rare in adults and not relevant to troubling ongoing symptoms in patients with Addison's disease. CASE PRESENTAT...

Several measurements are used to describe the behavior of a diabetic patient’s blood glucose. We describe a new, wavelet-based algorithm that indicates a new measurement called a PLA index could be used to quantify the variability or predictability of blood glucose. This wavelet-based approach emphasizes the shape of a blood glucose graph. Using continuous glucose monitors (CGMs), this measurem...